Risk based quality management in clinical trials workshop

French is available via eTranslation, the European Commission's machine translation service.

Translate to French | Important information about machine translation

Date

Lundi, 2 décembre 2013, Journée Entière

Emplacement

European Medicines Agency, Amsterdam, the Netherlands

The European Medicines Agency (EMA) is holding a one-and-a-half day workshop on risk based quality management in clinical trials. This workshop is being hosted by EMA in conjunction with the Clinical Trial Transformation Initiative (CTTI), a public-private partnership founded by the U.S. Food and Drug Administration (FDA) and Duke University. This workshop follows up the recent publication of the European reflection paper on 'Risk based quality management in clinical trials' after its public consultation. It intends to further develop understanding of risk based approach to quality management of clinical trials and promote discussions among stakeholders on how to move towards a more systematic, prioritised, risk-based approach to quality management of clinical trials in order to support the principles of Good Clinical Practice and to complement existing quality practices, requirements and standards.Registration closed.

Documents

Share this page